These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2961247)

  • 1. Systemic hypertension, left ventricular hypertrophy and coronary artery disease.
    Tubau JF; Szlachcic J; London MJ; Hollenberg M; Mangano D; Massie BM
    Am J Cardiol; 1987 Dec; 60(17):23I-28I. PubMed ID: 2961247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular hypertrophy and myocardial ischemia in systemic hypertension.
    Dunn FG; Pringle SD
    Am J Cardiol; 1987 Dec; 60(17):19I-22I. PubMed ID: 2961246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Heart effect of arterial hypertension. Heart hypertrophy as a risk factor. Study technics (electrocardiogram, echocardiography, exercise test and Holter].
    Aguilera Saldaña MA; García Moreno LM; Rodríguez Padial L; Navarro Lima A; Sánchez Domínguez J
    Rev Esp Cardiol; 1990; 43 Suppl 1():54-64. PubMed ID: 2139976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Left ventricular hypertrophy and myocardial ischemia (coronary atherosclerosis excluded)].
    Bounhoure JP; Galinier M
    Arch Mal Coeur Vaiss; 1991 Sep; 84 Spec No 3():107-10. PubMed ID: 1835363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphologic, hemodynamic and coronary perfusion characteristics in severe left ventricular hypertrophy secondary to systemic hypertension and evidence for nonatherosclerotic myocardial ischemia.
    Houghton JL; Carr AA; Prisant LM; Rogers WB; von Dohlen TW; Flowers NC; Frank MJ
    Am J Cardiol; 1992 Jan; 69(3):219-24. PubMed ID: 1530994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dipyridamole-echocardiography and thallium exercise myocardial scintigraphy in the diagnosis of obstructive coronary or microvascular disease in hypertensive patients with left ventricular hypertrophy and angina].
    Astarita C; Nicolai E; Liguori E; Gambardella S; Rumolo S; Maresca FS
    G Ital Cardiol; 1998 Sep; 28(9):996-1004. PubMed ID: 9788038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary hemodynamics in hypertensive heart disease. Basic concepts, clinical consequences, and experimental analysis of regression of hypertensive microangiopathy.
    Strauer BE
    Am J Med; 1988 Mar; 84(3A):45-54. PubMed ID: 2975465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of coronary artery disease on left ventricular systolic function and geometry in hypertensive patients with left ventricular hypertrophy (the LIFE study).
    Zabalgoitia M; Berning J; Koren MJ; Støylen A; Nieminen MS; Dahlöf B; Devereux RB;
    Am J Cardiol; 2001 Sep; 88(6):646-50. PubMed ID: 11564388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertensive heart disease: relationship of silent ischemia to coronary artery disease and left ventricular hypertrophy.
    Yurenev AP; DeQuattro V; Devereux RB
    Am Heart J; 1990 Oct; 120(4):928-33. PubMed ID: 2145735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary reserve in experimental myocardial hypertrophy.
    Gosse P; Clementy J
    Eur Heart J; 1995 Aug; 16 Suppl I():22-5. PubMed ID: 8829953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of left ventricular hypertrophy on the coronary circulation.
    Dellsperger KC; Marcus ML
    Am J Cardiol; 1990 Jun; 65(22):1504-10. PubMed ID: 2141226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of coronary circulation in hypertensive heart disease for development and prevention of heart failure.
    Strauer BE
    Am J Cardiol; 1990 Apr; 65(14):34G-41G. PubMed ID: 2138855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular hypertrophy, arrhythmias and sudden death in systemic hypertension.
    Borhani NO
    Am J Cardiol; 1987 Dec; 60(17):13I-18I. PubMed ID: 2961245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Coronary reserve in treated hypertension with persistent left ventricular hypertrophy].
    Antony I; Nitenberg A; Foult JM
    Arch Mal Coeur Vaiss; 1991 Aug; 84(8):1043-6. PubMed ID: 1835353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of cardiac function, geometry, energetics and coronary reserve in hypertensive heart disease.
    Strauer BE
    Nephron; 1987; 47 Suppl 1():76-86. PubMed ID: 2962004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary collateral circulation in coronary artery disease and systemic hypertension.
    Kyriakides ZS; Kremastinos DT; Michelakakis NA; Matsakas EP; Demovelis T; Toutouzas PK
    Am J Cardiol; 1991 Apr; 67(8):687-90. PubMed ID: 1826068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of thallium-201 scintigraphy in predicting the development of angina pectoris in hypertensive patients with left ventricular hypertrophy.
    Tubau JF; Szlachcic J; Hollenberg M; Massie BM
    Am J Cardiol; 1989 Jul; 64(1):45-9. PubMed ID: 2525866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Coronary reserve of the hypertensive heart: relationship to left ventricular hypertrophy].
    Fukai M; Ishihara T; Nakano T; Yamada Y; Tamoto S; Takada K; Ashida H; Fujiwara M; Shimada T; Seki I
    J Cardiol; 1990; 20(4):889-96. PubMed ID: 2151949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular hypertrophy. Significance in cardiac morbidity and mortality.
    Aronow WS
    Postgrad Med; 1990 Mar; 87(4):147-50, 155-8. PubMed ID: 2138288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ventricular arrhythmias in hypertensive left ventricular hypertrophy. Relationship to coronary artery disease, left ventricular dysfunction, and myocardial fibrosis.
    McLenachan JM; Dargie HJ
    Am J Hypertens; 1990 Oct; 3(10):735-40. PubMed ID: 2145865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.